bicalutamide and (S)-bicalutamide

bicalutamide has been researched along with (S)-bicalutamide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chesterson, GJ; Tucker, H1
Dence, CS; Jenks, C; Katzenellenbogen, JA; Parent, EE; Sharp, TL; Welch, MJ1
Aikawa, K; Baba, A; Hara, T; Hasuoka, A; Ito, M; Kaku, T; Kanzaki, N; Kobayashi, H; Yamamoto, S; Yamaoka, M1
Wang, S; Xiang, W1

Reviews

1 review(s) available for bicalutamide and (S)-bicalutamide

ArticleYear
Therapeutic Strategies to Target the Androgen Receptor.
    Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2022

Other Studies

3 other study(ies) available for bicalutamide and (S)-bicalutamide

ArticleYear
Resolution of the nonsteroidal antiandrogen 4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'- (trifluoromethyl)-propionanilide and the determination of the absolute configuration of the active enantiomer.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:4

    Topics: Androgen Antagonists; Anilides; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Isomerism; Male; Nitriles; Rats; Seminal Vesicles; Tosyl Compounds

1988
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
    Journal of medicinal chemistry, 2007, Mar-08, Volume: 50, Issue:5

    Topics: Androgen Antagonists; Anilides; Animals; Bromine Radioisotopes; Fluorine Radioisotopes; Isotope Labeling; Ligands; Male; Mice; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution; Tosyl Compounds

2007
Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists.
    Bioorganic & medicinal chemistry, 2013, Jan-01, Volume: 21, Issue:1

    Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Castration; Cell Line, Tumor; Drug Design; Humans; Male; Mice; Models, Molecular; Prostate; Prostatic Neoplasms; Pyrrolidines; Receptors, Androgen; Xenograft Model Antitumor Assays

2013